Abstract
ARID1A, a gene that encodes a subunit of the BAF (SWI/SNF) chromatin remodeling complex. Previous research on the ARID1A gene revealed that ARID1A deficiency was associated with a higher tumor mutation burden (TMB) level and mismatch repair (MMR) in cancer, which might cooperate with immune checkpoint blockade therapy. However, the features of ARID1A, its correlation with immunogenic marker, and the predictive value of immunotherapy for head and neck cancer remain unknown.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
